Peripheral oxytocin is associated with reduced symptom severity in schizophrenia

BACKGROUND: Emerging evidence from clinical trials suggests that oral estrogen and intranasal oxytocin might reduce symptom severity in schizophrenia. Whether increases in endogenous hormones are similarly associated with improved symptoms is unknown. We investigated the effects of menstrual cycle p...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Rubin, Leah H., Carter, C. Sue, Drogos, Lauren, Pournajafi-Nazarloo, Hossein, Sweeney, John A., Maki, Pauline M.
Médium: Artigo
Jazyk:Inglês
Vydáno: 2010
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC2981685/
https://ncbi.nlm.nih.gov/pubmed/20947304
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.schres.2010.09.014
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky